MID TO LARGE BIOPHARMA

MID TO LARGE BIOPHARMA

MID TO LARGE BIOPHARMA

As portfolios scale,
your precision matters

TA Scan's enterprise-ready intelligence helps sponsors design realistic studies, avoid protocol amendments, and choose sites with capacity to enroll.

Deliver Insight, Faster

Accelerate study planning with deep, validated data across global portfolios.

Reduce Trial Risk

Prevent delays by predicting recruitment challenges, site issues, and saturation early.

Scale across indications

Standardize feasibility and site selection across divisions, markets, and study teams.

Before/After

Why pharma choose TA Scan?

Before/After

Why pharma choose TA Scan?

Before/After

Why pharma choose TA Scan?

Without TA Scan

Slow, fragmented feasibility

Assumption-based site selection

Enrollment risks surface too late

Time lost in manual research

With TA Scan

Clear, consolidated clinical intelligence

Evidence-based site & country strategy

Predict enrollment challenges early

Faster feasibility — up to 2.5 weeks saved

Without TA Scan

Slow, fragmented feasibility

Assumption-based site selection

Enrollment risks surface too late

Time lost in manual research

With TA Scan

Clear, consolidated clinical intelligence

Evidence-based site & country strategy

Predict enrollment challenges early

Faster feasibility — up to 2.5 weeks saved

Without TA Scan

Slow, fragmented feasibility

Assumption-based site selection

Enrollment risks surface too late

Time lost in manual research

With TA Scan

Clear, consolidated clinical intelligence

Evidence-based site & country strategy

Predict enrollment challenges early

Faster feasibility — up to 2.5 weeks saved

Flexible intelligence that fits your planning workflow.

Deliver studies faster, with fewer amendments and stronger pipeline execution.

Validate protocols with real data

Forecast enrollment timelines

Find high-capacity sites & PIs

Avoid competition & delays

95%

Operational Confidence

Capacity signals helped teams make better decisions and reduce enrollment risk.

2.5M+

Investigator profiles

Global, continuously updated coverage across therapeutic areas, and study phases.

>100 hrs

Saved per study

Teams report saving up to 2.5 weeks in feasibility planning time.

What you get

How Pharma Use TA Scan

What you get

How Pharma Use TA Scan

What you get

How Pharma Use TA Scan

Market & Landscape Research

See the full competitive landscape.

Make strategic trial decisions with awareness of what's happening in the field.

Monitor overlapping trials, therapeutic activity, and emerging competitors to anticipate enrollment pressure and timing risk.

Market & Landscape Research

See the full competitive landscape.

Make strategic trial decisions with awareness of what's happening in the field.

Monitor overlapping trials, therapeutic activity, and emerging competitors to anticipate enrollment pressure and timing risk.

Due Diligence & Site Strategy

Select sites with proven ability to enroll.

Evaluate investigator experience, past enrollment, and site capacity signals to build a reliable recruitment strategy

Focus on partners who can confidently deliver.

Due Diligence & Site Strategy

Select sites with proven ability to enroll.

Evaluate investigator experience, past enrollment, and site capacity signals to build a reliable recruitment strategy

Focus on partners who can confidently deliver.

Data Efficiency & Operational Speed

Move faster with consolidated insights.

Reduce manual research time by bringing trial, site, and investigator intelligence into one clear view.

Teams report saving up to 2.5 weeks per study setup.

Data Efficiency & Operational Speed

Move faster with consolidated insights.

Reduce manual research time by bringing trial, site, and investigator intelligence into one clear view.

Teams report saving up to 2.5 weeks per study setup.

Validate protocol feasibility early

Ensure eligibility criteria, target patient populations, and study assumptions align with real-world site capacity.

Identify feasibility risks before they become costly protocol amendments.

Validate protocol feasibility early

Ensure eligibility criteria, target patient populations, and study assumptions align with real-world site capacity.

Identify feasibility risks before they become costly protocol amendments.

Market & Landscape Research

See the full competitive landscape.

Make strategic trial decisions with awareness of what's happening in the field.

Monitor overlapping trials, therapeutic activity, and emerging competitors to anticipate enrollment pressure and timing risk.

Market & Landscape Research

See the full competitive landscape.

Make strategic trial decisions with awareness of what's happening in the field.

Monitor overlapping trials, therapeutic activity, and emerging competitors to anticipate enrollment pressure and timing risk.

Due Diligence & Site Strategy

Select sites with proven ability to enroll.

Evaluate investigator experience, past enrollment, and site capacity signals to build a reliable recruitment strategy

Focus on partners who can confidently deliver.

Due Diligence & Site Strategy

Select sites with proven ability to enroll.

Evaluate investigator experience, past enrollment, and site capacity signals to build a reliable recruitment strategy

Focus on partners who can confidently deliver.

Data Efficiency & Operational Speed

Move faster with consolidated insights.

Reduce manual research time by bringing trial, site, and investigator intelligence into one clear view.

Teams report saving up to 2.5 weeks per study setup.

Data Efficiency & Operational Speed

Move faster with consolidated insights.

Reduce manual research time by bringing trial, site, and investigator intelligence into one clear view.

Teams report saving up to 2.5 weeks per study setup.

Validate protocol feasibility early

Ensure eligibility criteria, target patient populations, and study assumptions align with real-world site capacity.

Identify feasibility risks before they become costly protocol amendments.

Validate protocol feasibility early

Ensure eligibility criteria, target patient populations, and study assumptions align with real-world site capacity.

Identify feasibility risks before they become costly protocol amendments.

Validate protocol feasibility early

Ensure eligibility criteria, target patient populations, and study assumptions align with real-world site capacity.

Identify feasibility risks before they become costly protocol amendments.

See the full competitive landscape.

Make strategic trial decisions with awareness of what's happening in the field.

Monitor overlapping trials, therapeutic activity, and emerging competitors to anticipate enrollment pressure and timing risk.

Select sites with proven ability to enroll.

Evaluate investigator experience, past enrollment, and site capacity signals to build a reliable recruitment strategy

Focus on partners who can confidently deliver.

Move faster with consolidated insights.

Reduce manual research time by bringing trial, site, and investigator intelligence into one clear view.

Teams report saving up to 2.5 weeks per study setup.

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Top 10 pharma company

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Top 10 pharma company

“Because of TA Scan, we decreased the time it takes for that initial vetting of our sites, gaining an efficiency advantage in clinical operations”

Position

Data access

Flexible intelligence that fits your planning workflow

Data access

Flexible intelligence that fits your planning workflow

Data access

Flexible intelligence that fits your planning workflow

ADDITIONAL Resources

Explore Pharma Resources

ADDITIONAL Resources

Explore Pharma Resources

ADDITIONAL Resources

Explore Pharma Resources